Broyd · Biological psychiatry 2016 · systematic review · n=?

Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Cited 674 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review of empirical human studies evaluating acute and chronic cognitive outcomes

PubMed 26858214 · doi:10.1016/j.biopsych.2015.12.002 · record verified 2026-08-26

What was done

The authors systematically reviewed empirical human research published between January 2004 and February 2015 examining the acute and chronic effects of cannabis and cannabinoids on task-based neuropsychological measures of cognition, as well as cognitive persistence or recovery following abstinence. Findings were categorized across major cognitive domains, user sample characteristics, and cannabis consumption parameters.

What was found

The abstract reports no numerical effect sizes or quantitative meta-analytic statistics. Qualitatively, verbal learning, memory, and attention were the domains most consistently impaired by both acute and chronic cannabis exposure. Psychomotor performance showed the largest impairment during acute intoxication, with limited evidence of persistence in chronic users and after cessation. Impairments in verbal memory, attention, and select executive functions may persist after prolonged abstinence. Earlier age of cannabis onset was frequently linked to worse performance, little evidence supported tolerance to acute cognitive deficits, and evidence for cannabidiol mitigating harm remained preliminary.

Why it matters

This review synthesizes task-based cognitive outcomes across intoxication, chronic exposure, and abstinence, highlighting that memory and attention deficits can linger beyond acute intoxication. These findings provide a framework for harm-reduction guidelines and clinical screening as cannabis legalization expands.

Limits

The abstract does not disclose the total number of included studies, sample sizes, or effect estimates. Because findings combine acute experimental administrations with observational chronic-use cohorts, residual confounding (e.g., polydrug use, baseline cognitive differences) and variable abstinence durations limit causal conclusions regarding long-term recovery.

Cited by